Health and environment

Zuckerberg San Francisco General Hospital and Trauma Center and Agfa HealthCare Successfully Complete First Phase of Enterprise Imaging Strategy to Increase Information Access and Enhance Quality Patient Care

San Francisco”s only Trauma 1 facility deploys the latest version of Agfa HealthCare Enterprise Imaging, validating the integrated single platform advantage Agfa HealthCare announces the successful go-live implementation of the latest version of Enterprise Imaging in Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG). The solution consolidates imaging data from multiple service lines into one single database platform and provides secure access to a patient”s medical images, in one

FSD Pharma Receives License to Sell to Other Licensed Producers and Expands Growth Production Footprint

FSD Pharma Inc. (‘FSD Pharma‘ or the ‘Company‘) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that the license of its wholly-owned subsidiary, FV Pharma Inc. (‘FV Pharma’) under the Access to Cannabis for Medical Purposes Regulations (‘ACMPR’) has been migrated to the Cannabis Act and its regulations, effective November 8, 2018. The issuance of the new cannabis license includes the ability to sell cannabis to other licensed producers in

Hemp-Derived CBD Products Dominate Cannabis Market With Escalating Revenues

Financialnewsmedia.com News Commentary  Just as the legal cannabis industry has exploded in recent years, so too has a sector that revolves around the plant”s non-psychoactive cousin: hemp-based cannabidiol (CBD). Hemp-derived CBD products continue to dominate the cannabis market as less legal restrictions allow for companies to expand new products to previously untapped consumer segments. The demand for hemp-based cannabidiol has skyrocketed, especially since a 2013 CNN report about the success

Gerresheimer Increases Revenues by 8.8% and Successfully Integrates Sensile Medical

Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m  Adjusted EBITDA at constant exchange rates–excluding Sensile Medical and negative effects relating to the exemption from electricity network charges–increased by EUR 1.3m in third quarter to EUR 79.5m  Integration of Sensile Medical proceeding to plan; first product gains CE declaration of conformity  Outlook:  Revenue guidance for 2018, excluding Sensile Medical, as before between approximately EUR

Nurse Call Systems Market to Touch US$2.6 Bn With New Merger and Acquisition Strategies, Says TMR

As per the TMR report, the global nurse call systems market is anticipated to be worth US$2.6 bn by the end of 2025. The market is presumed to expand with 10.9% CAGR within the forecast period of 2017 to 2025. On the basis of end users, the hospitals segment is projected to be dominating the market because of the higher adoption and patient-centric approach that hospitals provide these days. Based

MYM Announces Resignation of Ian Ramage From Board of Directors

MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (MYM.CN). (the ‘Company’ or ‘MYM‘) announces today that the board of directors received the resignation of Director and General Counsel, Ian Ramage. Mr. Ramage joined the board of directors in February 2017. He resigns from the board to focus his efforts on other professional opportunities. ‘It is with mixed emotions that we announce the departure of our colleague and friend Ian Ramage,’ said Rob

Radiation Oncology Market Worth $10.1 Billion by 2025 | CAGR: 6.5%: Grand View Research, Inc.

The global radiation oncology market size is expected to reach USD 10.1 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to witness a CAGR of 6.5% over the forecast period. Rising prevalence of cancer is the primary factor responsible for substantial growth of the market for radiation oncology.      (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg ) Technological advancements resulted in increased adoption of radiation oncology as primary cancer

Radiation Oncology Market Worth $10.1 Billion by 2025 | CAGR: 6.5%: Grand View Research, Inc.

The global radiation oncology market size is expected to reach USD 10.1 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to witness a CAGR of 6.5% over the forecast period. Rising prevalence of cancer is the primary factor responsible for substantial growth of the market for radiation oncology.      (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg ) Technological advancements resulted in increased adoption of radiation oncology as primary cancer

Urinary Catheters Market to Exhibit 5.3% CAGR Owing to Rising Prevalence of Urological Conditions, Says TMR

As per expert analysts, the global urinary catheters market had registered revenue worth US$3,130.7 mn in 2016, which is further expected to expand at a steady CAGR of 5.3% during the forecast period from 2017 to 2025 to attain the value of around US$5,003.1 mn by the end of 2025. The intermittent catheters held topmost leading share in 2016 and hence exists as winner segment. This is mainly due to

Prefilled Syringes Market Worth $22.5 Billion by 2025 | CAGR 11.2%: Grand View Research, Inc.

The global prefilled syringes market size is expected to reach a value of USD 22.5 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 11.2% during the forecast years. Growing usage of prefilled syringes and technological advancements in auto-injectors are the key factors driving the market. Prefilled syringes are rapidly replacing traditional syringe-vial combinations due to advantages offered